Over 30 years ago, the International Classification of Retinopathy Of Prematurity (ICROP) provided an objective approach to diagnose retinopathy of prematurity (ROP), a disease of premature infants in which vascularization of the retina is incomplete or "immature," progressing to more advanced stages in some. [1] Wide-field imaging has made it possible to accurately document the retina upto the ora serrata to categorize ROP and study its outcome. [2, 3] The ROP classification was revisited over a decade ago, receiving a more robust and technical definition. [2] However, the precursor of ROP, namely, the extent of "immaturity" of the retina, has never been the focus. The progressive tapering of the retinal blood vessels in the absence of disease characterizes immature retina. The ICROP classification has defined incompletely vascularized retina as "immature" with no further subdivision. [2] There has been no quantification, stratification, or classification of the degree of avascularity that precedes the development of ROP despite the clinical reality that infants present with different extents of avascularity. This provides little prognostic value in predicting which of the infants with "immature" retina would progress to treatment-requiring disease and which ones would resolve spontaneously.
In this report, we evaluate the feasibility of predicting the course of ROP by classifying "disease-free," "immature" retina on the first screening visit documented using wide-field imaging. We aimed to study the correlation between the "severity of immaturity" and progression to disease, which would allow more intuitive follow-up and prognostication. Using this clinical validation, based on 1202 eyes, we discuss its clinical utility in helping to predict which babies may progress to Type 1 or Type 2 ROP and hence help in prognostication and follow-up.
Methods
This is a retrospective, multicenter, nonrandomized, observational, clinical validation study that was performed using the image database of the Karnataka Internet Assisted Diagnosis of Retinopathy of Prematurity (KIDROP) multicenter tele-ROP network. [4] [5] [6] [7] [8] [9] [10] [11] The KIDROP program and the study have met the approval of the Institute Research Board and the Institute Ethics Committee, and informed consents were obtained from the parents or guardians of all cases enrolled, analyzed, or treated. The study adhered to the tenets of the Declaration of Helsinki.
KIDROP currently performs tele-ROP screening in 104 neonatal units situated in rural, semi-urban, and urban areas of 30 districts of the south Indian state of Karnataka. Infants born ≤2000 g and or ≤34 weeks of gestation are enrolled into the program. [5, 6, 9] Inclusion criteria for this study included those infants who had completed the mandated ROP screening visits as per the national guidelines, [12] with the eyes having been imaged using a modified PHOTO-ROP protocol with a minimum of seven images (dilated anterior segment, disc, and macula center, and the four peripheral quadrants with the ora serrata included) on all visits. A RetCam Shuttle (Clarity MSI, USA) was used to obtain images of infants from these centers by a trained and accredited Level III technician during the study period of July 2013-December 2014. [6] The "first visit" images of 601 Asian Indian premature infants (1202 eyes) were retrieved from the KIDROP server database. Images of the first visit which demonstrated an "immature" retina alone with no evidence of any stage of ROP were selected. The rest of the images of these patients were also retrieved from the database, and the details of the course of the disease and patient demographics were collated on a Microsoft Excel worksheet (Microsoft Corporation, Redmond, WA, USA). The 601 infants had a median of four screening visits. Each visit had a median of 14 images per session. Of the 38,656 images retrieved, 135 images were discarded (0.35%), and the rest were reviewed and analyzed.
Based on the appearance of the first visit images of these enrolled infants, we classified the extent of immaturity of the retina as mild (Group 1), moderate (Group 2), and severe temporal avascular retina (TAR) (Group 3). After dividing the cohort into the above three groups, all serial follow-up visits of these babies were reviewed by two ROP specialists, masked to the group order to determine whether these babies had reached (during any subsequent visit) treatment-requiring ROP (Type I ROP), any stage ROP (Type II ROP), or vascularized spontaneously without developing any ROP. The outcome of these groups was then correlated with group order to determine whether the initial presentation could predict the final outcome by studying the association of the first visit immaturity with the final outcome. The secondary outcome of the study was to correlate the group order with the number of screening visits that the infant had undergone before the infant was discharged from the ROP screening program.
Statistical analysis
Descriptive statistics included mean and standard deviation for normally distributed variables and median and interquartile range (IQR) for non-normally distributed variables. Associations between the grades of immaturity and the outcome measures, namely, the presence of disease and the need for treatment, were evaluated in separate logistic regression models. Multivariate logistic regression models also included known risk factors associated with the outcome measures, namely, the birth weight, period of gestation, postmenstrual age (PMA), and gender. Statistical analyses were performed using a commercial software (Stata ver. 13.0; StataCorp, College Station, TX, USA). A P value of ≤ 0.05 was considered statistically significant in the multivariate regression models.
Results

Study cohort demographics
During the study period of 18 months, 1202 eyes of 601 premature infants fulfilling the inclusion criteria were enrolled for analysis. The mean birth weight was 1385 ± 290 g. The mean gestational age was 31.5 ± 2.5 weeks. The mean PMA at first screening was 35.58 ± 2.4 weeks. The distribution of the study groups with respect to the birth weight, gestational age, PMA, and the number of screening visits is summarized in Table 1 . The mean birth weight was found to be 1419 ± 274 g in Group 1, 1435 ± 308 in Group 2, and 1219 ± 290 in Group 3 (P < 0.05, one-way analysis of variance test). After applying Bonferroni's correction, the difference in means was found to be significant between mild and moderate versus severe but not between mild and moderate groups. The mean gestational age was found to be significantly different between the three groups: 32.2 ± 2.5 in Group 1, 31.1 ± 2.1 in Group 2, and 30.0 ± 2.6 in Group 3 (P < 0.05). Post hoc analysis noted a significant difference only between mild versus moderate and severe (P < 0.001) but not between moderate and severe (P = 0.241).
ROP distribution
Any stage ROP developed in 15% of eyes in Group 1, 46.5% of eyes in Group 2, and 100% of eyes in Group 3 during the entire follow-up period. While only 16 of 128 eyes (12.5%) in Group 1 required treatment, 12 of 72 (16.6%) and 28 of 44 of eyes (63.6%) in Groups 2 and 3, respectively, required treatment during their follow-up. Median (with IQR in brackets) number of visits in Group 1 was 4 (3-4), Group 2 was 4 (4-5), and Group 3 was 10 (8-11). Multivariate logistic regression evaluating the associations between birth weight, gender, PMA, grade of immaturity, and number of visits with the presence of disease and need for treatmentis represented in Table 2 . The results show that lower birth weight and lower PMA had greater odds of developing disease and requiring treatment. Lower birth weight was also associated with a greater number of visits. Male children had greater odds of developing disease and requiring treatment and needed more number of visits.
Predicted probability versus level of immaturity
Grade of immaturity at first visit showed a positive association with the development of disease, need for treatment, and higher number of visits, when adjusted for the other confounders (birth weight and PMA). The more severe the grade of immaturity at first visit, the greater the odds of developing disease and requiring treatment. Overall, predicted probability of developing any stage disease, according to our regression model, was 14% (12%-16%) in Group 1, 36% (30%-42%) in Group 2, and 67% (55%-77%) in Group 3. Similarly, predicted probability of requiring treatment, according to our regression model, was 1% (0%-2%) in Group 1, 5% (3%-9%) in Group 2, and 25% (13%-42%) in Group 3. In addition, the more severe the grade of immaturity, the greater the number of follow-up visits. The predicted number of visits in Group 1 was 4, Group 2 was 5, and Group 3 was 7.
Furthermore, we assessed the predicted probability of developing ROP at various birth weights and PMA according to the severity of immaturity [ Fig. 3a and b] . Thus, the predicted probability of developing disease, according to our model, for an infant with a birth weight of 1500 g was 15% [95% confidence interval (CI): 13%-17%] in Group 1. This increased to 35% (28%-42%) in Group 2. The probability of developing ROP in Group 3 was 100% irrespective of the birth weight. Similarly, the probability of developing ROP according to our model for a child with a PMA of 36 weeks was 14% (95% CI: 12%-16%) in Group 1. This increased to 28% (21%-37%) in Group 2. The probability of developing disease in Group 3 was 100% irrespective of the PMA. 
Case illustrations
Discussion
Immature retina, the precursor of ROP in preterm infants, has not been adequately categorized. The definition of "immature retina" according to the ICROP classification has been restricted to the "absence of disease marked by the progressive tapering of retinal bloods vessels stopping short of the ora serrata." [1, 2] The clinical relevance of retinal immaturity may be summarized as follows: (1) The degree of immaturity can extend from the posterior pole to a small, residual area in zone 3. Although these extremes receive an identical nomenclature of "immature retina," it is obvious that these do not have a similar clinical connotation in the real-world scenarios. (2) The extent of retinal immaturity correlates with the gestational and postnatal ages. Vasculogenesis starts from the center of the optic nerve around 10-12 weeks of gestation and reaches the ora serrata by 38-40 weeks of gestation. [13] (3) The larger the retinal avascular area, the larger the area that is potentially ischemic and higher are the chances of possible abnormal vascularization influenced by proangiogenic factors such as vascular endothelial growth factor. [13] The degree of retinal immaturity could be influenced by the level of postnatal care even before disease sets in. This is particularly true of developing nations where there is variable level of neonatal care that can result in severe immaturity that progresses to APROP. [14, 15] Hence, evaluating the level of immaturity especially before ROP develops could provide us with a method to predict which of these progresses to treatment requiring disease and when. In our program, all babies undergo serial RetCam imaging for all visits which allows us the opportunity to analyze the level of immaturity and compare it with the final ROP outcome.
In most circumstances, the subsequent follow-up after the first ROP screening visit is determined by the condition of the retina at the first event. [12, 16] If there is a "stage" of ROP, most screening protocols recommend weekly or fortnightly visits, unless it is Type 1, for which immediate treatment is recommended. However, scheduling the "right" follow-up date when there is "no stage" of ROP is more ambiguous with most protocols recommending a two-weekly visit if there is no disease but there is evidence of retinal immaturity. This poses a social, economic, and logistical challenge, especially where mothers have to travel long distances from the rural interiors for ROP screening of their infants. [8, 9, 17] Repeated or frequent follow-up visits have also been shown to increase the rate of attrition. [17] Incomplete ROP screening is both medicolegally [18] and clinically an unacceptable situation. [8, 10] To our best knowledge, this study is the first attempt to present a subclassification of the "immature" yet "not normal" retinal vascularization with the aim to predict the level of immaturity that could predict future disease and need closer follow-up [PubMed MeSH terms: immature retina, TAR, ROP].
ROP screening programs that rely predominantly on wide-field retinal imaging, wherein images are either read on site or remotely by experts, are becoming necessary and popular, [5, 6, 8, [19] [20] [21] [22] [23] [24] especially in middle-income countries, [6, 8, 9, 11] where there are limited number of ROP specialists and millions of babies to screen. [4, 25] In the Indian context, ROP screening recommends that the first screening be done before 30 days of life and for all infants born less than 2000 g at birth or born less than 34 weeks of gestation. The first screening is performed between 3 and 4 weeks of life for those born >28 weeks and 2-3 weeks for those born <28 weeks or <1200 g at birth. [5] Most babies require an average of four to five screening sessions, performed weekly or twice a month, until full vascularization of the retina is documented or the PMA is over 42-44 weeks or it reaches the threshold for treatment (Type 1 ROP). [5, 6] With an average incidence of 40% of any stage ROP [6, 7] and about 5%-10% of those requiring treatment, the number of "needless visits" before documenting a mature retina to be fit for discharge from the screening program poses a scientific, social, and logistic challenge. [8] [9] [10] [11] Our study shows that 100% of infants who had immature retina extending from zone 1 or posterior zone 2 would go on to develop some disease, and of these almost two-thirds would eventually require treatment. On the other end of the spectrum, only 15% of infants with retinal immaturity into zone 3 would develop any stage disease. Hence, the appearance of the retina at "first contact" could be used as a surrogate marker for predicting which babies are more likely to develop disease or more importantly need treatment. This is particularly relevant in ROP screening programs managed by nonphysician-based tele-ROP models using wide-field digital imaging in regions that lack experts. These units are required to give the clinical decision to the parents before the latter leave the center. [6, 9, 17, 26] A validated nomenclature of retinal immaturity would help them make a more prudent decision. Similarly, in physician-based screening programs, the ROP specialist who encounters a "severe" grade of immaturity could caution the mother about the impending progression and suggest a "closer follow-up." Furthermore, while babies get transferred from one neonatal intensive care unit to another, the extent of retinal immaturity can be quantified using this classification so that comparisons may be more uniformly objective when two or more physicians who share in the care of these infants examine and opine on these infants during ROP screening. Thus, the clinical utility of a "mild," "moderate," and " severe" immaturity includes a "closer watch" for infants with the "severe" grade of immaturity, with more detailed counseling, and warning and reminders if they miss any scheduled follow-up. As a corollary, infants who present initially with "milder" immaturity may have their next follow-up even 3-4 weeks later or closer to the expected due date to ensure and document a fully vascularized retina. Although the risk of progression to treatment-requiring disease is small, even these mildly immature retinae must be certified as "normal" before they are discharged from ROP screening. We also observed that more number of visits were needed in those with lower birth weights. Interestingly, male children had greater odds of developing disease or requiring treatment or needing more visits. All these factors can provide indicators for a closer follow-up in a community setup.
Our statistical model showed a predicted probability of developing disease to be 14% in Group 1, 36% in Group 2, and 67% in Group 3. The predicted probability of treatment-requiring disease was 1% in Group 1, 5% in Group 2, and 25% in Group 3. Additionally, the more severe the grade of immaturity, the greater the number of visits. The predicted number of visits in Group 1 was 4, Group 2 was 5, and Group 3 was 7. These indicate the need and rationale behind a more rigorous monitoring for those with severe TAR as against a conservative approach for those with mild or moderate TAR. The predictive probability estimates from our model closely mimic the observed values in the three groups of immaturity, serving therefore a reliable indicator of the model developed.
It is important to elaborate the differences between our results and the ETROP study [27] which had defined "low-risk" and "high-risk" prethreshold disease. Based on their definition and the RM-ROP2 risk assessment software, the low-risk group was defined as stage 2 ROP in zone 3 with no plus. It was observed that 44 of 292 (15%) of the low-risk group developed threshold ROP and <1% progressed to unfavorable outcome at 6 months. However, going by our classification of avascularity, eyes would have been classified to have "low risk" even before they developed any stage of ROP. Interestingly, and quite similarly, 14% of our "mild" (low risk) avascular group developed any stage ROP and 1% required treatment. This highlights the importance of classifying immature retina at the first screening visit.
The limitations of the study must be noted. First, this is a retrospective study. A prospective follow-up of these babies would provide a more chronological sequence of the worsening or improvement of the retinal immaturity. We have addressed this disadvantage by the inclusion of a relatively large sample of 1202 eyes. The post hoc power of the study for the given sample size was calculated and found to be 80%. Second, systemic risk factors and neonatal care practices have not been included in the correlation of the level of immaturity and its outcome. In the same ethnic group, we have previously reported the spontaneous regression for severe plus disease in a case of APROP by correction of thrombocytopenia. [28] Hence, other risk factor analysis may provide further insight into the extent of immaturity and the progression of disease. Third, we have used the posterior border of the clinically visible junction to classify the groups. While this is useful clinically and resembles the ICROP methodology of classifying disease based on the posterior most extent, it would disregard the fact that the posterior border dips especially at the temporal horizontal meridian, while the rest of the border may be more anterior resulting in a variable area of avascularity. The solution for this would be calculating the area using a third-party software like Image J, which could be used to determine the exact area of avascularity digitally in pixels. Finally, the study subjects belong exclusively to Asian Indian ethnicity and the cohort included for screening is much "heavier" and "older" than the screening criteria of developed countries such as the United States with mixed ethnicities. [29, 30] In the United States, the average birth weights and gestational ages would be significantly lower than this study, and hence the influence of these lower ages on the level of retinal immaturity and its subsequent progression to maturity is unknown, making these results less generalizable.
Conclusion
In conclusion, this suggested new subclassification of retinal immaturity and correlates clinically with the final disease outcome. Its clinical utility lies in offering the opportunity to the ROP specialist to schedule, follow-up, and prognosticate the level of disease and the timing of subsequent examinations while screening the baby for the first time. This could go a long way in reducing the economic burden and increasing compliance among mothers of ROP infants. With advances in automated imaging reading softwares, [31, 32] it may be possible, in the future, to predict which infants will progress to treatment-requiring disease based on metrics on these vascular patterns and which will spontaneously resolve. A prospective study involving multiple ethnicities and a lower range of birth weight and gestational ages would be needed to study the correlation of early retinal immaturity with the course of ROP.
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Commentary: Retinal immaturity at first screening and retinopathy of prematurity: Image-based validation of 1202 eyes of premature infants to predict disease progression Retinopathy of prematurity (ROP) has assumed epidemic proportions in India, thanks to the improved survival of low-birth-weight infants. If one considers the fact that every infant that is sent for screening requires a minimum of 2 visits to the retinologist even to declare normalcy, one can estimate the burden on the health care system. If unfortunately, they do have avascular retina or develop ROP, then the strain on the retinologist's time increases exponentially.
It is obvious that finding ways of predicting the occurrence of ROP is very useful in planning-in terms of focusing attention on infants at risk of developing ROP.
Pathogenetically one understands that the starting point is the presence of avascular retina secondary to the premature birth of the infant. [1] On top of this, more retina can become avascular by uncontrolled oxygen administration. The subsequent development of ROP, especially of the treatment-requiring stage, is dependent on several factors. Most studies have shown that in addition to the birth weight and gestation age, several postnatal factors influence the occurrence or otherwise of the treatment requiring stages of ROP, notable of which are, the number of days the infant is on ventilatory support, presence of respiratory distress syndrome, etc. [2] [3] [4] Most studies have also shown that the gestation age and birth weight are independent risk factors for the development of ROP (adjusted for the other postnatal factors). We also understand that the extent of the avascular (immature) retina at the time of the birth of the infant is roughly proportional to the gestation age and birth weight. Hence, one would intuitively suspect that the extent of the avascular retina at birth should be an important predictor of the occurrence of treatment requiring ROP.
In this issue of IJO, Vinekar et al. have published their results of a study wherein they graded the retinal immaturity at the time of primary screening and correlated it with the development of treatment requiring ROP subsequently. [5] They found that the degree of retinal immaturity does predict the occurrence of any ROP as well as treatment-requiring ROP.
The following factors need however to be considered while interpreting the results of this study. 1. The photographs were taken at the time of the first examination and not immediately after birth. Hence, they reflect the level of the immature retina at about 4 weeks after birth and not at birth 2. We also understand that the extent of the avascular retina at birth (which reflects the level immaturity of the infant) is likely to alter by 4 weeks in the following way a. In the absence of any adverse postnatal factor, the avascular retina is likely to reduce because of the natural progression of vascularization b. Under some conditions, the normal vascularization may not progress as it should and by 4 weeks when the first examination is done, it probably has remained unaltered c. Under conditions of poor neonatal care with uncontrolled oxygen administration, formed vasculature may be damaged and the extent of the avascular retina can actually be more than what it was at birth Unfortunately, there is no way to retrospectively assess what the extent of the avascular retina was at the time of birth from the pictures taken at 4 weeks after birth 3. Vinekar et al. have graded the extent of avascular retina based on the anterior-most point that the vascularization has reached. However, this does not always reflect the percentage of the area of the retina that is avascular. A sharp dip posteriorly of the anterior limit of retinal vascularization even by 1 clock hour (circumferentially) can push a case from mild group to moderate or even severe group, even when the surface area of the avascular retina is minimal. A study that quantifies the avascular retina as a percentage of the overall retinal area may be truly reflective of the contribution of the avascular retina alone as a factor for the development of ROP 4. It is also to be noted that eyes in group 1 (958 eyes) with vascularization touching the zone 3 still had 15% incidence of any ROP (128 eyes) and of these 12.5% (16 eyes) needed treatment, i.e. only 1.6% of the group 1 eyes develop treatment needing ROP. This information reduces the pressure on the diligence and frequency of follow up needed in this group, but it also tells us that despite avascular retina being restricted to zone 3, one cannot relax our vigil and a few of them may still end up in needing treatment.
